| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
-Tocopherol1
Division of Developmental Oncology Research, Mayo Clinic, Rochester, Minnesota 55905
Extravasation of Adriamycin during i.v. infusion can cause serious local complications. We have used a rat skin model to study the protection afforded by dimethyl sulfoxide and
-tocopherol (vitamin E) against Adriamycin-induced skin necrosis. Topical daily application of 1 ml dimethyl sulfoxide for 2 days produced a small decrease in ulcer diameter of up to 11% at 2 weeks. Topical daily applications of 1 ml 10%
-tocopherol succinate in dimethyl sulfoxide for 2 days produced a marked decrease in ulcer diameter at 2 weeks of up to 68%. Daily topical application of 1 ml 10%
-tocopherol succinate in dimethyl sulfoxide for 7 days offered no greater protection than 2-day application.
-Tocopherol acetate appeared to have activity slightly less than that of
-tocopherol succinate in reducing ulcer size, and both compounds were considerably more active than was
-tocopherol alcohol. Administration of
-tocopherol succinate or
-tocopherol acetate i.p. had no significant effect upon ulcer diameter. Topically applied dimethyl sulfoxide and
-tocopherol may provide an effective way of treating accidentally extravasated Adriamycin in cancer patients.
1 This work was supported by Grant CA 25337, awarded by NIH, Department of Health, Education, and Welfare, and American Cancer Society Grant CH 143.
2 To whom requests for reprints should be addressed.
Received 2/11/81. Accepted 6/ 8/81.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |